Mini ReviewOpen Access

Amniotic Membrane in the Treatment of Spinal Cord Injuries

Volume 1 - Issue 5

**Emilia Angela LoSchiavo Arisawa¹*, Luciana Barros Sant’Anna², Mariana de Castro Nicodemo¹, Eduarda Cesar da Luz Oliveira¹ and Débora Campos Chaves¹**

Author Information Open or Close
- ¹Biostimulation and Tissue Repair Laboratory, University of Paraíba Valley, Brazil
- ²Histology and Regenerative Therapy Laboratory, University of Paraíba Valley, Brazil
*Corresponding author: Emilia Angela Lo Schiavo Arisawa, Biostimulation and Tissue Repair Laboratory, University of Paraíba Valley, 2911 Shishima Hifumi Avenue, São José dos Campos, São Paulo, Brazil

Received: October 25, 2017; Published: October 30, 2017

DOI: 10.26717/BJSTR.2017.01.000475

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Spinal cord injury (SCI) is one of the most common and devastating injuries found in the neurological clinic [1,2]. It is defined as damage to the spinal cord that causes temporary or permanent changes in its function, resulting in significant neurological dysfunction and disability [3,4]. SCI has physical, social and occupational consequences for patients and their families, resulting in loss of independence and an increase in the mortality rate [3]. In addition, studies show that expenses for care of patients with SCI can reach US$1.1-4.6 million per patient throughout life. Thus, it is extremely important to develop effective treatments [5].

Abbreviations: SCI: Spinal Cord Injury; AM: Amniotic Membrane; AECs: Amniotic Epithelial Cells; AMSC: Amniotic Mesenchymal Stromal Cells

Mini Review| References|